Molecular techniques and prostate cancer diagnostic

被引:12
作者
Montironi, R [1 ]
Mazzucchelli, R [1 ]
Scarpelli, M [1 ]
机构
[1] Polytech Univ Marche Reg, Sch Med, Inst Pathol Anat & Histopathol, Azienda Osped Umberto 1, I-60020 Torrette, Ancona, Italy
关键词
fluorescence in situ hybridization; comparative genomic hybridization; reverse transcription; polymerase chain reaction; DNA array; laser capture microscopy; tissue microarray; prostate cancer;
D O I
10.1016/S0302-2838(03)00309-9
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Recent advances in molecular techniques have given the opportunity to assess genomic and proteomic alterations comprehensively and rapidly in routinely acquired tissue samples. In particular, new markers derived from qualitative and quantitative DNA, RNA, and protein analysis have provided additional objective information to supplant and extend the morphologic interpretations and have been increasingly integrated into the final surgical pathology diagnosis. In this review several recently developed molecular techniques are described and illustrated. The focus is on prostate cancer diagnostics, as an example of their application. (C) 2003 Elsevier B.V. All rights reserved.
引用
收藏
页码:390 / 400
页数:11
相关论文
共 81 条
[1]   Genomics and proteomics in cancer [J].
Baak, JPA ;
Path, FRC ;
Hermsen, MAJA ;
Meijer, G ;
Schmidt, J ;
Janssen, EAM .
EUROPEAN JOURNAL OF CANCER, 2003, 39 (09) :1199-1215
[2]   Biological aggressiveness of hereditary prostate cancer: Long-term evaluation following radical prostatectomy [J].
Bova, GS ;
Partin, AW ;
Isaacs, SD ;
Carter, BS ;
Beaty, TL ;
Isaacs, WB ;
Walsh, PC .
JOURNAL OF UROLOGY, 1998, 160 (03) :660-663
[3]  
Bowen C, 2000, CANCER RES, V60, P6111
[4]   Germline mutations in the ribonuclease L gene in families showing linkage with HPC1 [J].
Carpten, J ;
Nupponen, N ;
Isaacs, S ;
Sood, R ;
Robbins, C ;
Xu, J ;
Faruque, M ;
Moses, T ;
Ewing, C ;
Gillanders, E ;
Hu, P ;
Buinovszky, P ;
Makalowska, I ;
Baffoe-Bonnie, A ;
Faith, D ;
Smith, J ;
Stephan, D ;
Wiley, K ;
Brownstein, M ;
Gildea, D ;
Kelly, B ;
Jenkins, R ;
Hostetter, G ;
Matikainen, M ;
Schleutker, J ;
Klinger, K ;
Connors, T ;
Xiang, Y ;
Wang, Z ;
De Marzo, A ;
Papadopoulos, N ;
Kallioniemi, OP ;
Burk, R ;
Meyers, D ;
Grönberg, H ;
Meltzer, P ;
Silverman, R ;
Bailey-Wilson, J ;
Walsh, P ;
Isaacs, W ;
Trent, J .
NATURE GENETICS, 2002, 30 (02) :181-184
[5]   RNASEL Arg462Gln variant is implicated in up to 13% of prostate cancer cases [J].
Casey, G ;
Neville, PJ ;
Plummer, SJ ;
Xiang, Y ;
Krumroy, LM ;
Klein, EA ;
Catalona, WJ ;
Nupponen, N ;
Carpten, JD ;
Trent, JM ;
Silverman, RH ;
Witte, JS .
NATURE GENETICS, 2002, 32 (04) :582-583
[6]   Deletion, mutation, and loss of expression of KLF6 in human prostate cancer [J].
Chen, CS ;
Hyytinen, ER ;
Sun, XD ;
Helin, HJ ;
Koivisto, PA ;
Frierson, HF ;
Vessella, RL ;
Dong, JT .
AMERICAN JOURNAL OF PATHOLOGY, 2003, 162 (04) :1349-1354
[7]  
Chen H, 2003, J Med Genet, V40, pe21, DOI 10.1136/jmg.40.3.e21
[8]   COMPARATIVE GENOMIC HYBRIDIZATION, ALLELIC IMBALANCE, AND FLUORESCENCE IN-SITU HYBRIDIZATION ON CHROMOSOME-8 IN PROSTATE-CANCER [J].
CHER, ML ;
MACGROGAN, D ;
BOOKSTEIN, R ;
BROWN, JA ;
JENKINS, RB ;
JENSEN, RH .
GENES CHROMOSOMES & CANCER, 1994, 11 (03) :153-162
[9]   Genome-wide screening for complete genetic loss in prostate cancer by comparative hybridization onto cDNA microarrays [J].
Clark, J ;
Edwards, S ;
Feber, A ;
Flohr, P ;
John, M ;
Giddings, I ;
Crossland, S ;
Stratton, MR ;
Wooster, R ;
Campbell, C ;
Cooper, CS .
ONCOGENE, 2003, 22 (08) :1247-1252
[10]   Oligogenic segregation analysis of hereditary prostate cancer pedigrees: Evidence for multiple loci affecting age at onset [J].
Conlon, EM ;
Goode, EL ;
Gibbs, M ;
Stanford, JL ;
Badzioch, M ;
Janer, M ;
Kolb, S ;
Hood, L ;
Ostrander, EA ;
Jarvik, GP ;
Wusman, EM .
INTERNATIONAL JOURNAL OF CANCER, 2003, 105 (05) :630-635